Barclays Miami: enGene is looking to have pivotal data and to file for its non-viral delivered gene therapy for bladder cancer this year
Mar 10, 2026
05:55
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
CEO Ron Cooper describes why you need an alternative to virally delivered products for indications like bladder cancer. Plus, previewing a data update in the spring and 12 month data by the end of the year.
BiotechTV - News